neurology

News

Pandemic and currency headwinds hurt Roche in first half

Roche has announced half-year results showing the COVID-19 pandemic affected sales of its key products, with currency headwinds also weighing on revenues.

News

Closeup of X-ray photography of human brain

Biogen shares pop as it completes filing for Alzheimer's dru...

Biogen’s share price was up sharply on Wednesday after the big pharma completed its filing of its Alzheimer’s Disease (AD) drug aducanumab with the FDA.

News

Idorsia on course to take on Eisai and Merck & Co after late...

Switzerland’s Idorsia says it is on course to file a potential next-generation insomnia drug around the end of this year after a second batch of supportive phase 3 trial results, although t

News

NICE says no to Novartis’ Mayzent in secondary progressive M...

There isn’t enough evidence to back the use of Novartis Mayzent for secondary progressive multiple sclerosis on the NHS (SPMS), despite a desperate lack of treatments for this

News

Akili's ADHD digital therapy approved in Europe

The European Medicines Agency has approved Akili’s ground-breaking digital therapy for attention deficit hyperactivity disorder (ADHD), which uses a video game to treat the underlying cause

News

Lilly announces CNS tie-up with UK biotech Evox Therapeutics

Eli Lilly has announced a central nervous system research tie-up with UK biotech Evox Therapeutics, which focuses on drug engineering using vesicles to deliver drugs to targets.

Pandemic and currency headwinds hurt Roche in first half

Biogen shares pop as it completes filing for Alzheimer's dru...

Idorsia on course to take on Eisai and Merck & Co after late...

NICE says no to Novartis’ Mayzent in secondary progressive M...

Akili's ADHD digital therapy approved in Europe

Lilly announces CNS tie-up with UK biotech Evox Therapeutics

The long-delayed promise of the microbiome, with Sam Possemi...

How to meet your physicians where they are online

neurology

Editor's Picks